Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: NANOCOMPOSIX, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-01 to 2022-11-30
Current total value of award: $299040
Description: VACCINES ENABLING HIV PREVENTION TARGETING GERMINAL CENTER ENHANCEMENT WITH ENGINEERED SLOW RELEASE NANOPARTICLES